A low AMH result is one of the most common things to send someone spiraling on a fertility forum. If you’ve recently received yours and the number is lower than you hoped, it’s worth taking a breath before drawing conclusions. Low AMH does not mean you cannot get pregnant. It does not automatically mean IVF won’t work. What it means is that your ovarian reserve is lower than average for your age — and that certain approaches to treatment are likely to serve you better than the standard protocol.
What AMH Actually Measures
Anti-Müllerian hormone is produced by the small follicles in your ovaries. It’s used as a proxy for ovarian reserve — essentially a rough measure of how many eggs you have remaining. Low AMH suggests a smaller pool of eggs, but critically, it doesn’t tell you anything about the quality of the eggs you do have. Egg quality is primarily influenced by age, not by AMH level. This distinction matters enormously for treatment decisions.
A 33-year-old with low AMH has a very different prognosis than a 42-year-old with low AMH — not because the AMH is different, but because the 33-year-old’s eggs are statistically more likely to be chromosomally normal. AMH tells you about quantity. Age is the dominant driver of quality.
Why Standard IVF Protocols Often Underperform in Low AMH Patients
Conventional IVF uses high doses of follicle-stimulating hormones (gonadotropins) to stimulate the ovaries to produce as many eggs as possible in a single cycle. In patients with normal or high ovarian reserve, this often yields 10–20 eggs. In low AMH patients, the same aggressive stimulation frequently produces only 2–4 eggs — and sometimes the elevated medication doses don’t produce more eggs than a gentler protocol would. Worse, some research suggests that high stimulation may actually compromise egg quality in already-compromised patients by recruiting eggs that weren’t quite ready.
This is why the standard recommendation of “just do IVF” without protocol adjustment often fails low AMH patients not because IVF is wrong for them, but because the protocol is wrong for them.
IVF Approaches Better Suited to Low AMH
Mini IVF (Minimal Stimulation IVF)
Mini IVF uses significantly lower doses of injectable medications — often combined with oral medications like Clomid or Letrozole — to stimulate a smaller number of eggs. The goal is quality over quantity. For low AMH patients, the theory is that the body’s naturally selected few good eggs are retrieved rather than forcing the ovaries to produce eggs that may not have developed well under high-dose pressure.
Mini IVF also reduces medication costs (which can be $3,000–$6,000 of the total IVF cycle cost) and is associated with fewer side effects, including a very low risk of ovarian hyperstimulation syndrome (OHSS). Cycles can often be repeated more quickly. For some patients, multiple mini IVF cycles with PGT screening of each embryo becomes a cumulative strategy. You can learn more about Mini IVF at Hanabusa IVF, which specializes in this approach for patients who may not respond ideally to conventional protocols.
Natural Cycle IVF
In natural cycle IVF, little or no stimulation medication is used — the body’s naturally selected dominant follicle for that cycle is monitored and retrieved. While each cycle yields only one or two eggs, it can be repeated every month, and for patients who respond very poorly to stimulation, it may actually produce as many viable eggs over time as repeated stimulation attempts. The per-cycle success rate is lower, but the approach preserves access to the body’s own best-selected eggs.
Preimplantation Genetic Testing (PGT-A)
For low AMH patients who do proceed with IVF, PGT-A — chromosomal screening of embryos before transfer — can be particularly valuable. Given that only a small number of embryos will be produced per cycle, knowing that the one being transferred is chromosomally normal removes a major source of uncertainty. PGT-A increases the cost and complexity of a cycle, and it’s not right for everyone, but it’s worth a detailed conversation with your physician about whether it makes sense in your situation.
Lifestyle Factors With Evidence Behind Them
While no supplement or lifestyle change will dramatically reverse low AMH, a few interventions have enough supportive evidence to be worth discussing with your doctor:
- CoQ10 (Ubiquinol form): May support mitochondrial function in eggs; some studies show modest improvement in embryo quality in older or poor-responder patients. Typical dose 400–600 mg/day.
- DHEA: Some research supports supplementation in low-reserve patients to improve ovarian response — but only under medical supervision, as it affects hormone levels.
- Vitamin D: Deficiency is common and associated with poorer IVF outcomes; levels should be tested and normalized before starting a cycle.
- Minimizing alcohol and smoking: Both are associated with reduced egg quality and IVF success rates.
- Stress management: Chronic stress elevates cortisol, which can suppress reproductive hormone signaling. This is not the primary driver of low AMH, but reducing physiological stress where possible supports overall hormonal balance.
When Is Donor Egg IVF the Right Conversation?
Donor egg IVF involves using eggs from a screened, typically younger donor — fertilized with your partner’s or donor sperm — and transferring the resulting embryo to your uterus. Success rates with donor eggs are largely driven by the donor’s age and egg quality, not the recipient’s, which is why live birth rates with donor eggs can reach 60–70% regardless of the recipient’s age or AMH.
This is not a conversation that means you’ve run out of options. For many low AMH patients — particularly those over 40 — donor eggs represent the highest-probability path to parenthood and deserve to be presented as a real option, not a fallback of last resort. The right time to have this conversation is before multiple failed cycles have depleted you emotionally and financially.
Finding a Clinic That Understands Low Responders
Not every fertility clinic has deep experience managing low AMH patients well. Clinics that rely heavily on conventional high-dose protocols often produce disappointing results in this population — not because their physicians aren’t skilled, but because the protocol is not optimized for the patient in front of them.
Look for clinics that offer genuine protocol customization, have experience with minimal stimulation approaches, and will give you age-stratified success rates for poor responders specifically. Hanabusa IVF in San Diego focuses precisely on this population — patients with diminished ovarian reserve who need a more individualized approach than standard IVF delivers. If you’ve been told your AMH is too low for treatment, or if you’ve had a poor response to conventional stimulation, a second opinion from a specialist in this area is worth pursuing before you close any doors.
The Bottom Line
Low AMH is a piece of diagnostic information. It narrows the picture and informs the strategy, but it doesn’t write the ending. Many women with low AMH have gone on to have children — some with their own eggs through carefully tailored protocols, some through donor eggs. The path forward requires an honest conversation about your specific numbers, your age, your history, and your priorities — not a generic protocol designed for someone with completely different ovarian biology.
Victor Hearns is an American multi-genre writer. He is best known as the author of two series of some popular books. Victor was born in Jacksonville, FL but grew up in California with her grandmother. Her education includes degrees in English and Biology from Stanford University. In her free time, he helps people around the globe to live healthier & joyful life.
